Winzer C Eric's Form 4 filing
Nuo Therapeutics, Inc. (AURX) · filed Jul 2, 2026
- Accession no.
- 0001437749-26-022662
- Filed
- Jul 2, 2026, 8:59 PM ET
- Trade date
- Jun 29-30, 2026
- Filing delay
- 3 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 2 derivative transactions. It was filed 3 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Winzer C EricCIK 0001205362 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | Common Stock | MOption exerciseAcquired | +40,000 | $1.00 | +$40,000 | 212,654 | Direct | |
| Jun 30, 2026 | Common Stock | FTax withholdingDisposed | −39,604 | $1.01 | −$40,000.04 | 173,050 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | Common Stock | MOption exerciseDisposed | −40,000 | $0.00 | $0 | 0 | Direct | |
| Jun 29, 2026 | Common Stock | AGrant or awardAcquired | +30,000 | $0.00 | $0 | 30,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.